世界のインターフェロンアルファ(INN)市場予測 2020年-2025年

【英語タイトル】Global Interferon Alfa (INN) Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20JN05597)・商品コード:LPI20JN05597
・発行会社(調査会社):LP Information
・発行日:2020年6月20日
・ページ数:166
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:材料、化学
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥391,620見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥587,430見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥783,240見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「インターフェロンアルファ(INN)の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、長持ちタイプ、普通タイプなど、用途別には、肝炎、多発性硬化症、その他などに区分してまとめた調査レポートです。インターフェロンアルファ(INN)のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・インターフェロンアルファ(INN)の世界市場概要(サマリー)
・インターフェロンアルファ(INN)の企業別販売量・売上
・インターフェロンアルファ(INN)の企業別市場シェア
・インターフェロンアルファ(INN)の世界市場規模 2015年-2020年:種類別(長持ちタイプ、普通タイプ)
・インターフェロンアルファ(INN)の世界市場規模 2015年-2020年:用途別(肝炎、多発性硬化症、その他)
・インターフェロンアルファ(INN)の米州市場規模(アメリカ、カナダ、メキシコなど)
・インターフェロンアルファ(INN)のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・インターフェロンアルファ(INN)の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・インターフェロンアルファ(INN)の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・インターフェロンアルファ(INN)市場の成長要因・課題・動向
・インターフェロンアルファ(INN)の世界市場予測 2021年-2025年
・インターフェロンアルファ(INN)の米州市場予測(アメリカ、カナダ、メキシコなど)
・インターフェロンアルファ(INN)のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・インターフェロンアルファ(INN)の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・インターフェロンアルファ(INN)の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・インターフェロンアルファ(INN)の世界市場予測:種類別(長持ちタイプ、普通タイプ)
・インターフェロンアルファ(INN)の世界市場予測:用途別(肝炎、多発性硬化症、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Interferon Alfa (INN) market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Interferon Alfa (INN) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Interferon Alfa (INN) market by type, application, key manufacturers and key regions and countries.

This study considers the Interferon Alfa (INN) value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Long-lasting Type
Ordinary Type

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hepatitis
Multiple Sclerosis
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Merck KGaA
Anke Biotechnology
Merck & Co
Tri-Prime
Bayer
Novartis
Kawin
Biogen
Genzon Pharma
Zydus Cadila
Harbin Pharmaceutical
Huaxin Biotechnology

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Interferon Alfa (INN) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Interferon Alfa (INN) market by identifying its various subsegments.
Focuses on the key global Interferon Alfa (INN) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Interferon Alfa (INN) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Interferon Alfa (INN) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Interferon Alfa (INN) Consumption 2015-2025
2.1.2 Interferon Alfa (INN) Consumption CAGR by Region
2.2 Interferon Alfa (INN) Segment by Type
2.2.1 Long-lasting Type
2.2.2 Ordinary Type
2.3 Interferon Alfa (INN) Consumption by Type
2.3.1 Global Interferon Alfa (INN) Consumption Market Share by Type (2015-2020)
2.3.2 Global Interferon Alfa (INN) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Interferon Alfa (INN) Sale Price by Type (2015-2020)
2.4 Interferon Alfa (INN) Segment by Application
2.4.1 Hepatitis
2.4.2 Multiple Sclerosis
2.4.3 Others
2.5 Interferon Alfa (INN) Consumption by Application
2.5.1 Global Interferon Alfa (INN) Consumption Market Share by Type (2015-2020)
2.5.2 Global Interferon Alfa (INN) Value and Market Share by Type (2015-2020)
2.5.3 Global Interferon Alfa (INN) Sale Price by Type (2015-2020)

3 Global Interferon Alfa (INN) by Company
3.1 Global Interferon Alfa (INN) Sales Market Share by Company
3.1.1 Global Interferon Alfa (INN) Sales by Company (2018-2020)
3.1.2 Global Interferon Alfa (INN) Sales Market Share by Company (2018-2020)
3.2 Global Interferon Alfa (INN) Revenue Market Share by Company
3.2.1 Global Interferon Alfa (INN) Revenue by Company (2018-2020)
3.2.2 Global Interferon Alfa (INN) Revenue Market Share by Company (2018-2020)
3.3 Global Interferon Alfa (INN) Sale Price by Company
3.4 Global Interferon Alfa (INN) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Interferon Alfa (INN) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Interferon Alfa (INN) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Interferon Alfa (INN) by Regions
4.1 Interferon Alfa (INN) by Regions
4.2 Americas Interferon Alfa (INN) Consumption Growth
4.3 APAC Interferon Alfa (INN) Consumption Growth
4.4 Europe Interferon Alfa (INN) Consumption Growth
4.5 Middle East & Africa Interferon Alfa (INN) Consumption Growth

5 Americas
5.1 Americas Interferon Alfa (INN) Consumption by Countries
5.1.1 Americas Interferon Alfa (INN) Consumption by Countries (2015-2020)
5.1.2 Americas Interferon Alfa (INN) Value by Countries (2015-2020)
5.2 Americas Interferon Alfa (INN) Consumption by Type
5.3 Americas Interferon Alfa (INN) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Interferon Alfa (INN) Consumption by Regions
6.1.1 APAC Interferon Alfa (INN) Consumption by Regions (2015-2020)
6.1.2 APAC Interferon Alfa (INN) Value by Regions (2015-2020)
6.2 APAC Interferon Alfa (INN) Consumption by Type
6.3 APAC Interferon Alfa (INN) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Interferon Alfa (INN) by Countries
7.1.1 Europe Interferon Alfa (INN) Consumption by Countries (2015-2020)
7.1.2 Europe Interferon Alfa (INN) Value by Countries (2015-2020)
7.2 Europe Interferon Alfa (INN) Consumption by Type
7.3 Europe Interferon Alfa (INN) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Interferon Alfa (INN) by Countries
8.1.1 Middle East & Africa Interferon Alfa (INN) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Interferon Alfa (INN) Value by Countries (2015-2020)
8.2 Middle East & Africa Interferon Alfa (INN) Consumption by Type
8.3 Middle East & Africa Interferon Alfa (INN) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Interferon Alfa (INN) Distributors
10.3 Interferon Alfa (INN) Customer

11 Global Interferon Alfa (INN) Market Forecast
11.1 Global Interferon Alfa (INN) Consumption Forecast (2021-2025)
11.2 Global Interferon Alfa (INN) Forecast by Regions
11.2.1 Global Interferon Alfa (INN) Forecast by Regions (2021-2025)
11.2.2 Global Interferon Alfa (INN) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Interferon Alfa (INN) Forecast by Type
11.8 Global Interferon Alfa (INN) Forecast by Application

12 Key Players Analysis
12.1 Roche
12.1.1 Company Information
12.1.2 Interferon Alfa (INN) Product Offered
12.1.3 Roche Interferon Alfa (INN) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Roche Latest Developments
12.2 Merck KGaA
12.2.1 Company Information
12.2.2 Interferon Alfa (INN) Product Offered
12.2.3 Merck KGaA Interferon Alfa (INN) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Merck KGaA Latest Developments
12.3 Anke Biotechnology
12.3.1 Company Information
12.3.2 Interferon Alfa (INN) Product Offered
12.3.3 Anke Biotechnology Interferon Alfa (INN) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Anke Biotechnology Latest Developments
12.4 Merck & Co
12.4.1 Company Information
12.4.2 Interferon Alfa (INN) Product Offered
12.4.3 Merck & Co Interferon Alfa (INN) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Merck & Co Latest Developments
12.5 Tri-Prime
12.5.1 Company Information
12.5.2 Interferon Alfa (INN) Product Offered
12.5.3 Tri-Prime Interferon Alfa (INN) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Tri-Prime Latest Developments
12.6 Bayer
12.6.1 Company Information
12.6.2 Interferon Alfa (INN) Product Offered
12.6.3 Bayer Interferon Alfa (INN) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Bayer Latest Developments
12.7 Novartis
12.7.1 Company Information
12.7.2 Interferon Alfa (INN) Product Offered
12.7.3 Novartis Interferon Alfa (INN) Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Novartis Latest Developments
12.8 Kawin
12.8.1 Company Information
12.8.2 Interferon Alfa (INN) Product Offered
12.8.3 Kawin Interferon Alfa (INN) Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Kawin Latest Developments
12.9 Biogen
12.9.1 Company Information
12.9.2 Interferon Alfa (INN) Product Offered
12.9.3 Biogen Interferon Alfa (INN) Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Biogen Latest Developments
12.10 Genzon Pharma
12.10.1 Company Information
12.10.2 Interferon Alfa (INN) Product Offered
12.10.3 Genzon Pharma Interferon Alfa (INN) Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Genzon Pharma Latest Developments
12.11 Zydus Cadila
12.11.1 Company Information
12.11.2 Interferon Alfa (INN) Product Offered
12.11.3 Zydus Cadila Interferon Alfa (INN) Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Zydus Cadila Latest Developments
12.12 Harbin Pharmaceutical
12.12.1 Company Information
12.12.2 Interferon Alfa (INN) Product Offered
12.12.3 Harbin Pharmaceutical Interferon Alfa (INN) Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Harbin Pharmaceutical Latest Developments
12.13 Huaxin Biotechnology
12.13.1 Company Information
12.13.2 Interferon Alfa (INN) Product Offered
12.13.3 Huaxin Biotechnology Interferon Alfa (INN) Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Huaxin Biotechnology Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Interferon Alfa (INN) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Long-lasting Type
Table 5. Major Players of Ordinary Type
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Interferon Alfa (INN) Consumption Market Share by Type (2015-2020)
Table 8. Global Interferon Alfa (INN) Revenue by Type (2015-2020) ($ million)
Table 9. Global Interferon Alfa (INN) Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Interferon Alfa (INN) Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Interferon Alfa (INN) Consumption Market Share by Application (2015-2020)
Table 13. Global Interferon Alfa (INN) Value by Application (2015-2020)
Table 14. Global Interferon Alfa (INN) Value Market Share by Application (2015-2020)
Table 15. Global Interferon Alfa (INN) Sale Price by Application (2015-2020)
Table 16. Global Interferon Alfa (INN) Sales by Company (2017-2019) (K Doses)
Table 17. Global Interferon Alfa (INN) Sales Market Share by Company (2017-2019)
Table 18. Global Interferon Alfa (INN) Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Interferon Alfa (INN) Revenue Market Share by Company (2017-2019)
Table 20. Global Interferon Alfa (INN) Sale Price by Company (2017-2019)
Table 21. Global Interferon Alfa (INN) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Interferon Alfa (INN) Products Offered
Table 23. Interferon Alfa (INN) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Interferon Alfa (INN) Consumption by Regions 2015-2020 (K Doses)
Table 25. Global Interferon Alfa (INN) Consumption Market Share by Regions 2015-2020
Table 26. Global Interferon Alfa (INN) Value by Regions 2015-2020 ($ Millions)
Table 27. Global Interferon Alfa (INN) Value Market Share by Regions 2015-2020
Table 28. Americas Interferon Alfa (INN) Consumption by Countries (2015-2020) (K Doses)
Table 29. Americas Interferon Alfa (INN) Consumption Market Share by Countries (2015-2020)
Table 30. Americas Interferon Alfa (INN) Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Interferon Alfa (INN) Value Market Share by Countries (2015-2020)
Table 32. Americas Interferon Alfa (INN) Consumption by Type (2015-2020) (K Doses)
Table 33. Americas Interferon Alfa (INN) Consumption Market Share by Type (2015-2020)
Table 34. Americas Interferon Alfa (INN) Consumption by Application (2015-2020) (K Doses)
Table 35. Americas Interferon Alfa (INN) Consumption Market Share by Application (2015-2020)
Table 36. APAC Interferon Alfa (INN) Consumption by Countries (2015-2020) (K Doses)
Table 37. APAC Interferon Alfa (INN) Consumption Market Share by Countries (2015-2020)
Table 38. APAC Interferon Alfa (INN) Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Interferon Alfa (INN) Value Market Share by Regions (2015-2020)
Table 40. APAC Interferon Alfa (INN) Consumption by Type (2015-2020) (K Doses)
Table 41. APAC Interferon Alfa (INN) Consumption Market Share by Type (2015-2020)
Table 42. APAC Interferon Alfa (INN) Consumption by Application (2015-2020) (K Doses)
Table 43. APAC Interferon Alfa (INN) Consumption Market Share by Application (2015-2020)
Table 44. Europe Interferon Alfa (INN) Consumption by Countries (2015-2020) (K Doses)
Table 45. Europe Interferon Alfa (INN) Consumption Market Share by Countries (2015-2020)
Table 46. Europe Interferon Alfa (INN) Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Interferon Alfa (INN) Value Market Share by Countries (2015-2020)
Table 48. Europe Interferon Alfa (INN) Consumption by Type (2015-2020) (K Doses)
Table 49. Europe Interferon Alfa (INN) Consumption Market Share by Type (2015-2020)
Table 50. Europe Interferon Alfa (INN) Consumption by Application (2015-2020) (K Doses)
Table 51. Europe Interferon Alfa (INN) Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Interferon Alfa (INN) Consumption by Countries (2015-2020) (K Doses)
Table 53. Middle East & Africa Interferon Alfa (INN) Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Interferon Alfa (INN) Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Interferon Alfa (INN) Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Interferon Alfa (INN) Consumption by Type (2015-2020) (K Doses)
Table 57. Middle East & Africa Interferon Alfa (INN) Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Interferon Alfa (INN) Consumption by Application (2015-2020) (K Doses)
Table 59. Middle East & Africa Interferon Alfa (INN) Consumption Market Share by Application (2015-2020)
Table 60. Interferon Alfa (INN) Distributors List
Table 61. Interferon Alfa (INN) Customer List
Table 62. Global Interferon Alfa (INN) Consumption Forecast by Countries (2021-2025) (K Doses)
Table 63. Global Interferon Alfa (INN) Consumption Market Forecast by Regions
Table 64. Global Interferon Alfa (INN) Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Interferon Alfa (INN) Value Market Share Forecast by Regions
Table 66. Global Interferon Alfa (INN) Consumption Forecast by Type (2021-2025) (K Doses)
Table 67. Global Interferon Alfa (INN) Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Interferon Alfa (INN) Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Interferon Alfa (INN) Value Market Share Forecast by Type (2021-2025)
Table 70. Global Interferon Alfa (INN) Consumption Forecast by Application (2021-2025) (K Doses)
Table 71. Global Interferon Alfa (INN) Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Interferon Alfa (INN) Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Interferon Alfa (INN) Value Market Share Forecast by Application (2021-2025)
Table 74. Roche Product Offered
Table 75. Roche Interferon Alfa (INN) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 76. Roche Main Business
Table 77. Roche Latest Developments
Table 78. Roche Basic Information, Company Total Revenue (in $ million), Interferon Alfa (INN) Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck KGaA Product Offered
Table 80. Merck KGaA Interferon Alfa (INN) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 81. Merck KGaA Main Business
Table 82. Merck KGaA Latest Developments
Table 83. Merck KGaA Basic Information, Company Total Revenue (in $ million), Interferon Alfa (INN) Manufacturing Base, Sales Area and Its Competitors
Table 84. Anke Biotechnology Product Offered
Table 85. Anke Biotechnology Interferon Alfa (INN) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 86. Anke Biotechnology Main Business
Table 87. Anke Biotechnology Latest Developments
Table 88. Anke Biotechnology Basic Information, Company Total Revenue (in $ million), Interferon Alfa (INN) Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck & Co Product Offered
Table 90. Merck & Co Interferon Alfa (INN) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 91. Merck & Co Main Business
Table 92. Merck & Co Latest Developments
Table 93. Merck & Co Basic Information, Company Total Revenue (in $ million), Interferon Alfa (INN) Manufacturing Base, Sales Area and Its Competitors
Table 94. Tri-Prime Product Offered
Table 95. Tri-Prime Interferon Alfa (INN) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 96. Tri-Prime Main Business
Table 97. Tri-Prime Latest Developments
Table 98. Tri-Prime Basic Information, Company Total Revenue (in $ million), Interferon Alfa (INN) Manufacturing Base, Sales Area and Its Competitors
Table 99. Bayer Product Offered
Table 100. Bayer Interferon Alfa (INN) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 101. Bayer Main Business
Table 102. Bayer Latest Developments
Table 103. Bayer Basic Information, Company Total Revenue (in $ million), Interferon Alfa (INN) Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis Product Offered
Table 105. Novartis Basic Information, Company Total Revenue (in $ million), Interferon Alfa (INN) Manufacturing Base, Sales Area and Its Competitors
Table 106. Novartis Main Business
Table 107. Novartis Latest Developments
Table 108. Novartis Interferon Alfa (INN) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 109. Kawin Product Offered
Table 110. Kawin Interferon Alfa (INN) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 111. Kawin Main Business
Table 112. Kawin Latest Developments
Table 113. Kawin Basic Information, Company Total Revenue (in $ million), Interferon Alfa (INN) Manufacturing Base, Sales Area and Its Competitors
Table 114. Biogen Product Offered
Table 115. Biogen Interferon Alfa (INN) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 116. Biogen Main Business
Table 117. Biogen Latest Developments
Table 118. Biogen Basic Information, Company Total Revenue (in $ million), Interferon Alfa (INN) Manufacturing Base, Sales Area and Its Competitors
Table 119. Genzon Pharma Product Offered
Table 120. Genzon Pharma Interferon Alfa (INN) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 121. Genzon Pharma Main Business
Table 122. Genzon Pharma Latest Developments
Table 123. Genzon Pharma Basic Information, Company Total Revenue (in $ million), Interferon Alfa (INN) Manufacturing Base, Sales Area and Its Competitors
Table 124. Zydus Cadila Product Offered
Table 125. Zydus Cadila Interferon Alfa (INN) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 126. Zydus Cadila Main Business
Table 127. Zydus Cadila Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Zydus Cadila Latest Developments
Table 129. Harbin Pharmaceutical Product Offered
Table 130. Harbin Pharmaceutical Interferon Alfa (INN) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 131. Harbin Pharmaceutical Main Business
Table 132. Harbin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Harbin Pharmaceutical Latest Developments
Table 134. Huaxin Biotechnology Product Offered
Table 135. Huaxin Biotechnology Interferon Alfa (INN) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 136. Huaxin Biotechnology Main Business
Table 137. Huaxin Biotechnology Latest Developments
Table 138. Huaxin Biotechnology Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Interferon Alfa (INN)
Figure 2. Interferon Alfa (INN) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Interferon Alfa (INN) Consumption Growth Rate 2015-2025 (K Doses)
Figure 5. Global Interferon Alfa (INN) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Long-lasting Type
Figure 7. Product Picture of Ordinary Type
Figure 8. Global Interferon Alfa (INN) Consumption Market Share by Type (2015-2020)
Figure 9. Global Interferon Alfa (INN) Value Market Share by Type (2015-2020)
Figure 10. Interferon Alfa (INN) Consumed in Hepatitis
Figure 11. Global Interferon Alfa (INN) Market: Hepatitis (2015-2020) (K Doses)
Figure 12. Global Interferon Alfa (INN) Market: Hepatitis (2015-2020) ($ Millions)
Figure 13. Interferon Alfa (INN) Consumed in Multiple Sclerosis
Figure 14. Global Interferon Alfa (INN) Market: Multiple Sclerosis (2015-2020) (K Doses)
Figure 15. Global Interferon Alfa (INN) Market: Multiple Sclerosis (2015-2020) ($ Millions)
Figure 16. Interferon Alfa (INN) Consumed in Others
Figure 17. Global Interferon Alfa (INN) Market: Others (2015-2020) (K Doses)
Figure 18. Global Interferon Alfa (INN) Market: Others (2015-2020) ($ Millions)
Figure 19. Global Interferon Alfa (INN) Consumption Market Share by Application (2015-2020)
Figure 20. Global Interferon Alfa (INN) Value Market Share by Application (2015-2020)
Figure 21. Global Interferon Alfa (INN) Sales Market Share by Company in 2017
Figure 22. Global Interferon Alfa (INN) Sales Market Share by Company in 2019
Figure 23. Global Interferon Alfa (INN) Revenue Market Share by Company in 2017
Figure 24. Global Interferon Alfa (INN) Revenue Market Share by Company in 2019
Figure 25. Global Interferon Alfa (INN) Sale Price by Company in 2019
Figure 26. Global Interferon Alfa (INN) Consumption Market Share by Regions 2015-2020
Figure 27. Global Interferon Alfa (INN) Value Market Share by Regions 2015-2020
Figure 28. Americas Interferon Alfa (INN) Consumption 2015-2020 (K Doses)
Figure 29. Americas Interferon Alfa (INN) Value 2015-2020 ($ Millions)
Figure 30. APAC Interferon Alfa (INN) Consumption 2015-2020 (K Doses)
Figure 31. APAC Interferon Alfa (INN) Value 2015-2020 ($ Millions)
Figure 32. Europe Interferon Alfa (INN) Consumption 2015-2020 (K Doses)
Figure 33. Europe Interferon Alfa (INN) Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Interferon Alfa (INN) Consumption 2015-2020 (K Doses)
Figure 35. Middle East & Africa Interferon Alfa (INN) Value 2015-2020 ($ Millions)
Figure 36. Americas Interferon Alfa (INN) Consumption Market Share by Countries in 2019
Figure 37. Americas Interferon Alfa (INN) Value Market Share by Countries in 2019
Figure 38. Americas Interferon Alfa (INN) Consumption Market Share by Type in 2019
Figure 39. Americas Interferon Alfa (INN) Consumption Market Share by Application in 2019
Figure 40. United States Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 41. United States Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 43. Canada Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 45. Mexico Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Interferon Alfa (INN) Consumption Market Share by Countries in 2019
Figure 47. APAC Interferon Alfa (INN) Value Market Share by Regions in 2019
Figure 48. APAC Interferon Alfa (INN) Consumption Market Share by Type in 2019
Figure 49. APAC Interferon Alfa (INN) Consumption Market Share by Application in 2019
Figure 50. China Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 51. China Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 53. Japan Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 55. Korea Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 57. Southeast Asia Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 58. India Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 59. India Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 61. Australia Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Interferon Alfa (INN) Consumption Market Share by Countries in 2019
Figure 63. Europe Interferon Alfa (INN) Value Market Share by Countries in 2019
Figure 64. Europe Interferon Alfa (INN) Consumption Market Share by Type in 2019
Figure 65. Europe Interferon Alfa (INN) Consumption Market Share by Application in 2019
Figure 66. Germany Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 67. Germany Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 68. France Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 69. France Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 70. UK Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 71. UK Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 73. Italy Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 75. Russia Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Interferon Alfa (INN) Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Interferon Alfa (INN) Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Interferon Alfa (INN) Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Interferon Alfa (INN) Consumption Market Share by Application in 2019
Figure 80. Egypt Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 81. Egypt Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 83. South Africa Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 85. Israel Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 87. Turkey Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Interferon Alfa (INN) Consumption Growth 2015-2020 (K Doses)
Figure 89. GCC Countries Interferon Alfa (INN) Value Growth 2015-2020 ($ Millions)
Figure 90. Global Interferon Alfa (INN) Consumption Growth Rate Forecast (2021-2025) (K Doses)
Figure 91. Global Interferon Alfa (INN) Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 93. Americas Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 94. APAC Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 95. APAC Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 96. Europe Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 97. Europe Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 99. Middle East & Africa Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 100. United States Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 101. United States Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 102. Canada Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 103. Canada Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 104. Mexico Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 105. Mexico Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 106. Brazil Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 107. Brazil Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 108. China Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 109. China Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 110. Japan Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 111. Japan Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 112. Korea Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 113. Korea Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 115. Southeast Asia Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 116. India Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 117. India Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 118. Australia Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 119. Australia Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 120. Germany Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 121. Germany Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 122. France Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 123. France Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 124. UK Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 125. UK Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 126. Italy Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 127. Italy Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 128. Russia Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 129. Russia Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 130. Spain Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 131. Spain Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 132. Egypt Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 133. Egypt Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 134. South Africa Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 135. South Africa Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 136. Israel Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 137. Israel Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 138. Turkey Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 139. Turkey Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Interferon Alfa (INN) Consumption 2021-2025 (K Doses)
Figure 141. GCC Countries Interferon Alfa (INN) Value 2021-2025 ($ Millions)
Figure 142. Roche Interferon Alfa (INN) Market Share (2018-2020)
Figure 143. Merck KGaA Interferon Alfa (INN) Market Share (2018-2020)
Figure 144. Anke Biotechnology Interferon Alfa (INN) Market Share (2018-2020)
Figure 145. Merck & Co Interferon Alfa (INN) Market Share (2018-2020)
Figure 146. Tri-Prime Interferon Alfa (INN) Market Share (2018-2020)
Figure 147. Bayer Interferon Alfa (INN) Market Share (2018-2020)
Figure 148. Novartis Interferon Alfa (INN) Market Share (2018-2020)
Figure 149. Kawin Interferon Alfa (INN) Market Share (2018-2020)
Figure 150. Biogen Interferon Alfa (INN) Market Share (2018-2020)
Figure 151. Genzon Pharma Interferon Alfa (INN) Market Share (2018-2020)
Figure 152. Zydus Cadila Interferon Alfa (INN) Market Share (2018-2020)
Figure 153. Harbin Pharmaceutical Interferon Alfa (INN) Market Share (2018-2020)
Figure 154. Huaxin Biotechnology Interferon Alfa (INN) Market Share (2018-2020)


★調査レポート[世界のインターフェロンアルファ(INN)市場予測 2020年-2025年] (コード:LPI20JN05597)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のインターフェロンアルファ(INN)市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆